FAM
VKTX icon

Formidable Asset Management’s Viking Therapeutics VKTX Stock Holding History

Formidable Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Sell
64,099
-3,787
-6% -$122K 0.34% 55
2026
Q1 		$2.36M Sell
67,886
-1,999
-3% -$64.3K 0.37% 49
2025
Q4 		$1.92M Buy
69,885
+21,625
+45% +$766K 0.28% 68
2025
Q3 		$1.28M Buy
48,260
+2,381
+5% +$71K 0.2% 95
2025
Q2 		$1.13M Buy
45,879
+5,111
+13% +$135K 0.19% 102
2025
Q1 		$985K Buy
40,768
+9,896
+32% +$313K 0.16% 119
2024
Q4 		$1.24M Sell
30,872
-2,487
-7% -$142K 0.2% 96
2024
Q3 		$2.11M Buy
33,359
+7,639
+30% +$448K 0.34% 60
2024
Q2 		$1.36M Buy
25,720
+6,132
+31% +$402K 0.22% 94
2024
Q1 		$1.61M Buy
+19,588
New +$872K 0.26% 78

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Formidable Asset Management's VKTX Position: Q2 2026 in Review

Formidable Asset Management reduced its Viking Therapeutics (VKTX) stake by 5.6% in Q2 2026, selling an estimated $122K and leaving 64,099 shares worth $2.14M. The position accounts for 0.34% of the portfolio, ranked #55.

Formidable Asset Management first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.36M in Q1 2026. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Formidable Asset Management held 64,099 shares of Viking Therapeutics worth $2.14M as of Q2 2026.
  • Formidable Asset Management sold 3,787 Viking Therapeutics shares in Q2 2026, an estimated $122K.
  • Viking Therapeutics made up 0.34% of Formidable Asset Management's portfolio in Q2 2026, its #55 holding.
  • Formidable Asset Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Formidable Asset Management's Viking Therapeutics position peaked at $2.36M in Q1 2026.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.